Donanemab detects a minor fraction of amyloid-β plaques in post-mortem brain tissue of patients with Alzheimer's disease and Down syndrome

Acta Neuropathol. 2022 May;143(5):601-603. doi: 10.1007/s00401-022-02418-3. Epub 2022 Apr 16.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease*
  • Amyloid beta-Peptides / metabolism
  • Brain / metabolism
  • Down Syndrome*
  • Humans
  • Plaque, Amyloid

Substances

  • Amyloid beta-Peptides